Form 10-Q · Quarterly report
Snap-on 10-Q, filed Jul 23, 2026
- Filed
- CIK
- 0000091440
- Accession no.
- 0000091440-26-000144
Summary
Snap-on reported second-quarter 2026 net sales of $1.235 billion, up 4.7% from a year earlier, and net earnings attributable to the company of $260.6 million, or $4.96 per diluted share. For the first six months, net sales rose 5.2% to $2.442 billion and net earnings attributable to Snap-on were $507.6 million, or $9.65 per diluted share.
Key points
- Second-quarter net sales increased 4.7% to $1.235 billion, reflecting a 3.0% organic gain, $11.5 million of acquisition-related sales, and $8.7 million of favorable foreign currency translation.
- Second-quarter gross margin rose 90 basis points to 51.4%, helped by higher sales volumes and savings from Snap-on's RCI initiatives.
- Second-quarter net earnings attributable to Snap-on were $260.6 million, or $4.96 per diluted share, compared with $250.3 million, or $4.72 per diluted share, a year earlier.
- First-half net sales rose 5.2% to $2.442 billion, while net earnings attributable to Snap-on rose to $507.6 million from $490.8 million.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
From the filing
Item 2: Management’s Discussion RESULTS OF OPERATIONS Results of operations for the three months ended July 4, 2026, and June 28, 2025, are as follows: Three Months Ended (Amounts in millions) July 4, 2026 June 28, 2025 Change Net sales $ 1,235.1 100.0 % $ 1,179.4 100.0 % $ 55.7 4.7 % Cost of goods sold (599.9) (48.6) % (583.9) (49.5) % (16.0) (2.7) % Gross profit 635.2 51.4 % 595.5 50.5 % 39.7 6.7 % Operating expenses (366.3) (29.6) % (336.4) (28.5) % (29.9) (8.9) % Operating earnings before financial services 268.9 21.8 % 259.1 22.0 % 9.8 3.8 % Financial services revenue 99.7 100.0 % 101.7 100.0 % (2.0) (2.0) % Financial services expenses (32.2) (32.3) % (33.5) (32.9) % 1.3 3.9 %…
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.